Catalyst Wire Dossier Catalyst Wire Dossier

OnabotulinumtoxinA

botulinum toxin type A · Allergan (AbbVie)
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for OnabotulinumtoxinA, covering 2008-09-29 to 2026-06-16. Get the full timeline:

Most recent: Clinical Trial Results: Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine [Phase 3]

See pricing